Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antifungal Prophylaxis
100%
Antifungal Therapy
20%
Clinical Outcomes
20%
Clinical Trials
20%
Drug Interactions
20%
Drug Toxicity
20%
Epidemiology
20%
Hematological Malignancies
100%
Hematopoietic Stem Cell Transplant Recipients
100%
Hematopoietic Stem Cell Transplantation
20%
High Mortality
20%
High Risk
100%
Immunocompromised Patients
20%
Infection Risk
20%
Invasive Aspergillosis
20%
Invasive Candidiasis
20%
Invasive Fungal Infection
80%
Neutropenic Patients
20%
Resistance Emergence
20%
Risk Factors
20%
Timely Diagnosis
20%
Medicine and Dentistry
Antifungal Therapy
25%
Clinical Trial
25%
Cohort Effect
50%
Drug Interaction
25%
Drug Toxicity
25%
Hematologic Malignancy
100%
Hematopoietic Stem Cell Transplantation
100%
Immunocompromised Patient
25%
Invasive Aspergillosis
25%
Systemic Candidiasis
25%
Systemic Mycosis
100%
Immunology and Microbiology
Cohort Effect
50%
Drug Interaction
25%
Drug Toxicity
25%
Epidemiology
50%
Hematopoietic Stem Cell Transplantation
100%
Immunocompromised Patient
25%
Infection
100%
Infectious Disease
100%
Pharmacology, Toxicology and Pharmaceutical Science
Antifungal Therapy
25%
Clinical Trial
25%
Drug Interaction
25%
Drug Toxicity
25%
Epidemiology
50%
Hematologic Malignancy
100%
Immunocompromised Patient
25%
Invasive Aspergillosis
25%
Invasive Candidiasis
25%
Systemic Mycosis
100%